ELGX News and Press, Endologix Inc. From 06/23/19

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that John Onopchenko, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, will present at the 2019 BMO Prescriptions for Success Healthcare Conference at ...

Endologix® Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been reinstated by GMED, the EU Notified Body f...

Introduction My new CFO insider trading anomaly study has completed the first month of tracking beginning at the start of April 2019. The ongoing study is retesting multiple aspects of peer-reviewed studies in the financial literature for the next 12 months. This new anomaly study will repla...

The following slide deck was published by Endologix, Inc. in conjunction with their 2019 Q1 earnings Read more ...

Endologix, Inc. (ELGX) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants John Onopchenko – Chief Executive Officer Vaseem Mahboob – Chief Financial Officer Matt Thompson – Chief Medical Officer Conference Call Participants Mat...

Endologix (NASDAQ: ELGX ): Q1 GAAP EPS of -$2.12 misses by $0.44 . More news on: Endologix, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the first quarter ended March 31, 2019. “Our first quarter financial and operational performance provide...

Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the first quarter of fiscal year 2019 after the market close on Thursday, May 2, 2019. The Company’s management will ho...